Performance characteristics of the ARK Diagnostics gabapentin immunoassay

Therapeutic Drug Monitoring

Volumn 33, Issue 4, 2011, Pages 398-401

  Juenke, Joetta M ^a   Wienhoff, Kavina A ^a   Anderson, Brent L ^a   McMillin, Gwendolyn A ^a,b   Johnson Davis, Kamisha L ^a,b  

^a ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Gabapentin; Immunoassay; Therapeutic drug monitoring

Indexed keywords

GABAPENTIN;

ARTICLE; AUTOANALYZER; CLINICAL ARTICLE; DRUG MONITORING; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

AMINES; ANTICONVULSANTS; BLOOD CHEMICAL ANALYSIS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOHEXANECARBOXYLIC ACIDS; DRUG MONITORING; GAMMA-AMINOBUTYRIC ACID; HUMANS; IMMUNOASSAY; SEIZURES; TANDEM MASS SPECTROMETRY;

EID: 80051798787     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0b013e318220bb65     Document Type: Article

References (18)

1. Krasowski MD. Therapeutic drug monitoring of newer anti-epilepsy Medications. Pharmaceuticals. 2010;3:1909-1935.
2. Bar Ad V. Gabapentin for the treatment of cancer-related pain syndromes. Rev Recent Clin Trials. 2010;5:174-178.
3. Parikh HG, Dash SK, Upasani CB. Study of the effect of oral gabapentin used as preemptive analgesia to attenuate post-operative pain in patients undergoing abdominal surgery under general anesthesia. Saudi J Anaesth. 2010;4:137-141.
4. Ucak A, Onan B, Sen H, et al. The effects of gabapentin on acute and chronic postoperative pain after coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth. 2011 (Epub ahead of print).
5. Moore A, Costello J, Wieczorek P, et al. Gabapentin improves postceserean delivery pain management: a randomized, placebo-controlled trial. Anesth Analg. 2011;112:167-173.
6. Backonja M, Beydoun A, Edwards KR. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA. 1998;280:1831-1836. (Pubitemid 28544423)
7. Mathew NT, Rapoport A, Saper J. Efficacy of gabapentin in migraine prophylaxis. Headache. 2001;41:119-128. (Pubitemid 32209899)
8. Ellenbogen AL, Thein SG, Winslow DH, et al. A 52-week study of gabapentin enacarbil in restless legs syndrome. Clin Neuropharmacol. 2011;34:8-16.
9. Gabriel A. Gabapentin adjunctive to risperidone or olanzapine in partially responsive schizophrenia: an open-label pilot study. Neuropsychiatr Dis Treat. 2010;6:711-717.
10. Pande AC, Pollack MH, Crockatt J. Placebo-controlled study of gabapentin treatment of panic disorder. J Clin Psychopharmacol. 2000; 20:467-471. (Pubitemid 30463763)
11. Pande AC, Davidson JR, Jefferson JW. Treatment of social phobia with gabapentin: a placebo-controlled study. J Clin Psychopharmacol. 1999; 19:341-348. (Pubitemid 29344848)
12. Gidal BE, Radulovic LL, Kruger S, et al. Inter- and Intra-subject variability in gabapentin absorption and absolute bioavailability. Epilepsy Res. 2000;40:123-127. (Pubitemid 30339403)
13. Patsalos PN, Berry DJ, Bourgeois BF, et al. Antiepileptic drugs-best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia. 2008;49:1239-1276. (Pubitemid 351991390)
14. Lindberger M, Luhr O, Johannessen SI, et al. Serum concentrations and effects of gabapentin and vigabatrin: observations from a dose titration study. Ther Drug Monit. 2003;25:457-462. (Pubitemid 36927977)
15. Juenke JM, Brown PI, McMillin GA, et al. Procedure for the monitoring of gabapentin with 2,4,6-trinitrobenzene sulfonic acid derivatization followed by HPLC with ultraviolet detection. Clin Chem. 2003;49: 1198-1201. (Pubitemid 36751114)
16. Kolocouri F, Dotsikas Y, Loukas YL. Dried plasma spots as an alternative sample collection technique for the quantitative LC-MS/ MS determination of gabapentin. Anal Bioanal Chem. 2010;398: 1339-1347.
17. Kushnir MM, Crossett J, Brown PI, et al. Analysis of gabapentin in serum and plasma by solid phase extraction and gas chromatography-mass spectrometry for therapeutic drug monitoring. J Anal Toxicol. 1999;23:1-6. (Pubitemid 29327445)
18. Juenke JM, Brown PI, Johnson-Davis KL, et al. Simultaneous Quantification of levetiracetam and gabapentin in plasma by ultrahighpressure liquid chromatography with tandem mass spectrometric detection. Ther Drug Monitor. 2011;33:209-213.